Nurix Therapeutics Inc (NRIX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $16.11
• Market Cap: $1.62B
• EPS: $-3.05
• 52-Week High: $22.50
• 52-Week Low: $8.18

Market Sentiment

Nurix Therapeutics Inc currently has a Neutral sentiment score of -0.10.

About Nurix Therapeutics Inc

Nurix Therapeutics, Inc. is a San Francisco-based biopharmaceutical company focused on the discovery and development of novel small molecule therapies for cancer and immune disorders. Utilizing its proprietary drug discovery platform, Nurix pioneers targeted protein degradation to develop innovative treatment options aimed at enhancing patient outcomes in oncology and immunology. With a strong commitment to advancing cutting-edge therapeutics, Nurix is well-positioned as a compelling investme...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Nurix Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NRIX pay dividends?

Nurix Therapeutics Inc (NRIX) does not currently pay a regular dividend.

What is NRIX's market cap?

Nurix Therapeutics Inc (NRIX) has a market capitalization of $1.62B with a current stock price of $16.11.